Valuation: Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Market Cap 12.45B 1.83B 1.61B 1.48B 1.37B 2.6B 175B 2.65B 17.82B 6.92B 85.76B 6.87B 6.72B 298B P/E 2026 *
123x
P/E 2027 * 94.1x
Enterprise Value 12.45B 1.83B 1.61B 1.48B 1.37B 2.6B 175B 2.65B 17.82B 6.92B 85.76B 6.87B 6.72B 298B EV / Sales 2026 *
11.4x
EV / Sales 2027 * 10.1x
Free-Float
64.5%
Yield 2026 *
-
Yield 2027 * -
06-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 9 June 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-21 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announces Annual dividend, payable on June 09, 2026 CI
04-20 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding CI
04-06 Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million. CI
03-31 Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake RE
12-15 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
12-14 Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million. CI
11-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections CI
27/10/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
09/10/25 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
28/09/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. completed the acquisition of 30% stake in Suzhou Chuangyang New Materials Technology Co., Ltd. from Shanghai Miaoxiang Enterprise Management Consulting Co., Ltd., Taicang Chuangyang Qiyun Enterprise Management Partnership Enterprise (Limited Partnership), Shanghai Shizhi Enterprise Management Co., Ltd. and Shanghai Jiuban Intelligent Technology Co., Ltd. CI
09/09/25 Shandong Linuo Pharmaceutical Packaging's shareholder to unload shares RE
1 day+5.31%
1 week-28.27%
Current month-28.27%
1 month-12.25%
3 months+126.15%
6 months+169.61%
Current year+172.67%
1 week 44.6
Extreme 44.6
62.25
1 month 44.6
Extreme 44.6
76.3
Current year 15.07
Extreme 15.07
76.3
1 year 15.07
Extreme 15.07
76.3
3 years 10.78
Extreme 10.78
76.3
5 years 10.78
Extreme 10.78
76.3
10 years 10.78
Extreme 10.78
76.3
Manager TitleAgeSince
Chief Executive Officer 46 14/04/2024
Director of Finance/CFO 45 28/11/2022
Investor Relations Contact - -
Director TitleAgeSince
Chairman 51 30/10/2025
Chairman 47 31/12/2023
Director/Board Member 54 05/04/2015
Change 5-day change 1-year change 3-year change Capi.($)
+5.31%-28.27%+138.28%+185.32% 1.74B
-2.33%+5.38%-4.03%+18.59% 3.63B
-2.08%+5.10%-29.84%-40.90% 2.72B
+0.94%-1.25%-17.07%-33.14% 1.76B
-3.55%-0.73%-39.75%-55.12% 1.51B
-2.86%-0.70%-18.25%-52.02% 739M
+0.52%-5.59%+35.09%+39.10% 602M
-3.30%-3.39%+64.63%+45.61% 594M
+0.33%+2.11%-41.49%-55.07% 451M
-1.97%-3.49%+110.49%+106.59% 381M
Average -0.85%-1.05%+19.81%+15.90% 1.41B
Weighted average by Cap. -0.75%+0.87%+8.76%+11.65%

Financials

2026 *2027 *
Net sales 1.09B 160M 141M 130M 120M 227M 15.34B 232M 1.56B 606M 7.51B 602M 588M 26.06B 1.24B 182M 160M 147M 136M 258M 17.42B 263M 1.77B 688M 8.53B 683M 668M 29.6B
Net income 103M 15.14M 13.28M 12.26M 11.33M 21.47M 1.45B 21.9M 147M 57.26M 709M 56.85M 55.61M 2.46B 137M 20.14M 17.66M 16.31M 15.07M 28.56M 1.93B 29.13M 196M 76.17M 944M 75.62M 73.96M 3.28B
Net Debt - -
Logo Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.
Employees
1,403
Date Price Change Volume
07/07/26 CN¥47.99 +5.31% 29,657,773
07/07/26 CN¥45.57 -3.12% 15,014,644
06/07/26 CN¥47.04 -8.75% 22,553,950
03/07/26 CN¥51.55 -10.25% 29,221,149
02/07/26 CN¥57.44 -9.40% 24,780,815

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 301188 Stock